We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Blood Gas Analyzer Focuses on Safety at POC

By LabMedica International staff writers
Posted on 29 Dec 2010
A new blood gas analyzer was designed specifically to be used at the point of care (POC).

The compact cobas b 123 is ideal for use in critical care units, emergency rooms, and other POC settings. More...
Easy to use and virtually maintenance free, it incorporates a number of important infection control features and ensures minimal downtime with reliable, clot-free operation.

The only manual maintenance step required for the new instrument is the replacement of consumables.
Its highly durable electronics and mechanics make it robust and reliable, ensuring minimal downtime and saving time required at the machine. Clot-free operation ensures that there is no unnecessary disruption to routine or waste of reagents.

The instrument requires minimal training of staff. With touch screen operation, the system guides the user through operational processes systematically. The press of a single button is all that is required to initiate sampling and measurement.

The new analyzer has many infection control and safety features. There are no exposed needles and the protected sample input area remains closed during operation and between samples. Infection control is further enhanced by the collection of waste in a sealed pack within the closed system. Password authorization ensures safe and appropriate use by locking the instrument to unauthorized/untrained users.

The cobas b 123 includes all important critical care parameters including blood gases, hematocrit, bilirubin, electrolytes, glucose, and lactate. To make interpretation of results as easy as possible, the large, color display screen presents unambiguous readings, with measurements that fall outside predefined acceptable limits highlighted clearly.

The need for scanning barcodes and swapping the consumables across instruments is made redundant by Smart chips on the consumables (sensors, fluid packs, and quality control--QC packs). Because sensors are separate from the fluid pack, the latter can be stored at room temperature. Inventory status is displayed clearly on the screen and step-by-step prompts guide the user through the changing of consumables.

The footprint of the analyzer for environments where there is limited space is reduced by the front loading feature. Data can be transferred across instruments using a simple media card.

The new cobas b 123 POC system is the latest blood gas analyzer from Roche (Basel, Switzerland). It is due to be launched in the UK and Ireland in February 2011.

Dr. Thomas Vering, head of the Roche global sensor program, commented, "Consolidation of important critical care tests on one system allows medical professionals in critical care and emergency settings to obtain rapid answers to a broad range of medical questions. The cobas b 123 is flexible and configurable to accommodate individual needs and with its intuitive operation and excellent connectivity options, it is ideal for use at the point of care.”

Related Links:
Roche



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

Oncology diagnostics rely on pathology and biomarker information to guide personalized treatment. As computational pathology and artificial intelligence (AI) expand insights from tissue analysis, laboratories... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.